BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29263312)

  • 21. The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis.
    Pizzi M; Gergis U; Chaviano F; Orazi A
    Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):96-104. PubMed ID: 27521149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Splenic irradiation as a component of a reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in myelofibrosis with massive splenomegaly.
    Ito T; Akagi K; Kondo T; Kawabata H; Ichinohe T; Takaori-Kondo A
    Tohoku J Exp Med; 2012 Dec; 228(4):295-9. PubMed ID: 23117264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathomechanism and clinical impact of myelofibrosis in neoplastic diseases of the bone marrow].
    Bedekovics J; Méhes G
    Orv Hetil; 2014 Mar; 155(10):367-75. PubMed ID: 24583557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties.
    Urs NM; Gee SM; Pack TF; McCorvy JD; Evron T; Snyder JC; Yang X; Rodriguiz RM; Borrelli E; Wetsel WC; Jin J; Roth BL; O'Donnell P; Caron MG
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8178-E8186. PubMed ID: 27911814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation: a study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow Transplantation.
    Alchalby H; Zabelina T; Stübig T; van Biezen A; Bornhäuser M; Di Bartolomeo P; Beelen D; Cahn JY; Dreger P; Schroyens W; de Witte T; Olavarria E; Kröger N;
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):279-81. PubMed ID: 24201159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary myelofibrosis and its targeted therapy.
    Shantzer L; Berger K; Pu JJ
    Ann Hematol; 2017 Apr; 96(4):531-535. PubMed ID: 27539616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shp-2 heterozygous hematopoietic stem cells have deficient repopulating ability due to diminished self-renewal.
    Chan RJ; Li Y; Hass MN; Walter A; Voorhorst CS; Shelley WC; Yang Z; Orschell CM; Yoder MC
    Exp Hematol; 2006 Sep; 34(9):1230-9. PubMed ID: 16939816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen signaling selectively induces apoptosis of hematopoietic progenitors and myeloid neoplasms without harming steady-state hematopoiesis.
    Sánchez-Aguilera A; Arranz L; Martín-Pérez D; García-García A; Stavropoulou V; Kubovcakova L; Isern J; Martín-Salamanca S; Langa X; Skoda RC; Schwaller J; Méndez-Ferrer S
    Cell Stem Cell; 2014 Dec; 15(6):791-804. PubMed ID: 25479752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Janus Kinase Inhibitors and Stem Cell Transplantation in Myelofibrosis.
    El Fakih R; Popat U
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S34-42. PubMed ID: 26297276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells.
    Wang X; Hu CS; Petersen B; Qiu J; Ye F; Houldsworth J; Eng K; Huang F; Hoffman R
    Blood Adv; 2018 Sep; 2(18):2378-2388. PubMed ID: 30242099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interrelation of the osteogenic and hemopoietic tissues of the bone marrow during the development of estrogenic myelofibrosis].
    Ivasenko IN
    Arkh Anat Gistol Embriol; 1989 Nov; 97(11):92-8. PubMed ID: 2631646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiopathic myelofibrosis.
    Barosi G; Hoffman R
    Semin Hematol; 2005 Oct; 42(4):248-58. PubMed ID: 16210038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6.
    Rontauroli S; Norfo R; Pennucci V; Zini R; Ruberti S; Bianchi E; Salati S; Prudente Z; Rossi C; Rosti V; Guglielmelli P; Barosi G; Vannucchi A; Tagliafico E; Manfredini R
    Oncotarget; 2017 Mar; 8(13):21380-21397. PubMed ID: 28423484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal analysis of agnogenic myeloid metaplasia.
    Kreipe H; Jaquet K; Felgner J; Parwaresch MR
    Leuk Lymphoma; 1992 Dec; 8(6):459-64. PubMed ID: 1363649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients.
    Ruberti S; Bianchi E; Guglielmelli P; Rontauroli S; Barbieri G; Tavernari L; Fanelli T; Norfo R; Pennucci V; Fattori GC; Mannarelli C; Bartalucci N; Mora B; Elli L; Avanzini MA; Rossi C; Salmoiraghi S; Zini R; Salati S; Prudente Z; Rosti V; Passamonti F; Rambaldi A; Ferrari S; Tagliafico E; Vannucchi AM; Manfredini R
    Leukemia; 2018 Feb; 32(2):438-449. PubMed ID: 28745329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders.
    Martyré MC
    Leuk Lymphoma; 1995 Dec; 20(1-2):39-44. PubMed ID: 8750621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1 low Model of Myelofibrosis.
    Spangrude GJ; Lewandowski D; Martelli F; Marra M; Zingariello M; Sancillo L; Rana RA; Migliaccio AR
    Stem Cells; 2016 Jan; 34(1):67-82. PubMed ID: 26439305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups.
    Deeg HJ; Bredeson C; Farnia S; Ballen K; Gupta V; Mesa RA; Popat U; Hari P; Saber W; Seftel M; Tamari R; Petersdorf EW
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1883-7. PubMed ID: 26371371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis.
    Tripodo C; Di Bernardo A; Ternullo MP; Guarnotta C; Porcasi R; Ingrao S; Gianelli U; Boveri E; Iannitto E; Franco G; Florena AM
    Haematologica; 2009 Jan; 94(1):127-30. PubMed ID: 19029148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial-to-Mesenchymal Transition in Bone Marrow and Spleen of Primary Myelofibrosis.
    Erba BG; Gruppi C; Corada M; Pisati F; Rosti V; Bartalucci N; Villeval JL; Vannucchi AM; Barosi G; Balduini A; Dejana E
    Am J Pathol; 2017 Aug; 187(8):1879-1892. PubMed ID: 28728747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.